A new study announced by Eli Lilly appears to suggest Olumiant, a rheumatoid arthritis drug, does not need the same label warnings for heart problems as Xeljanz, it's competitor.
A new study suggests the risk of heart problems linked to Xeljanz is similar across all other rheumatoid arthritis drugs belonging to the same class of medications.
The eczema cream Opzelura, made from the same active ingredient as Jakafi, is being investigated for texture issues as the entire class of drugs faces scrutiny over heart and cancer…
A new study raises questions about whether testosterone therapy actually increases the risk of blood clots in men with hypogonadism.
A new study suggests vaping with nicotine-based e-cigarettes can increase the risk of blood clots, potentially leading to heart attacks and strokes.
The FDA is requiring new label warnings for Xeljanz and similar drugs, following a review which revealed links between increased risks of heart attacks, strokes, blood clots, and lymphomas, as…
A Tasigna lawsuit claims the side effects of the CML drug caused a woman to suffer a stroke due to a blocked carotid artery.
The FDA wants the makers of Lipitor, Crestor and similar cholesterol drugs to remove contraindications from the labels banning use by pregnant women, saying some may need the drugs due…
A Tasigna wrongful death lawsuit claims a New Jersey man's mother died of a heart attack after the CML drug caused her to develop coronary artery disease and other ailments.
All Tasigna lawsuits filed in New Jersey state courts have been consolidated before one judge for pretrial proceedings.